Non-Hodgkin's lymphoma refractory

Clinical trials for Non-Hodgkin's lymphoma refractory explained in plain language.

Never miss a new study

Get alerted when new Non-Hodgkin's lymphoma refractory trials appear

Sign up with your email to follow new studies for Non-Hodgkin's lymphoma refractory, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Radiation boost may help CAR t therapy work better for tough lymphomas

Disease control Ongoing

This early-phase study tests whether giving radiation therapy before standard CAR T cell treatment is safe and practical for people with B-cell lymphoma that has come back or not responded to prior treatments. About 20 participants will receive split-course bridging radiation to …

Matched conditions: NON-HODGKIN'S LYMPHOMA REFRACTORY

Phase 1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 07:56 UTC

Non-Hodgkin's lymphoma refractory

Get alerted when new Non-Hodgkin's lymphoma refractory trials appear

Radiation boost may help CAR t therapy work better for tough lymphomas